Head to head: should the intraductal component of invasive prostate cancer be graded?
Genitourinary Pathology Society
Gleason grading
International Society of Urological Pathologists
intraductal carcinoma
prostate
Journal
Histopathology
ISSN: 1365-2559
Titre abrégé: Histopathology
Pays: England
ID NLM: 7704136
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
04
07
2020
revised:
13
07
2020
accepted:
16
07
2020
pubmed:
22
7
2020
medline:
28
9
2021
entrez:
22
7
2020
Statut:
ppublish
Résumé
The reporting of intraductal carcinoma of the prostate (IDCP) is controversial, with conflicting recommendations having recently been published by the International Society of Urological Pathology (ISUP) and the Genitourinary Pathology Society (GUPS). Both recommend that isolated (pure) IDCP should not be graded. However, the ISUP recommends incorporating the IDCP component of invasive prostate cancer in the Gleason score, whereas the GUPS recommends reporting IDCP as a comment, independently of the Gleason score. The arguments for and against incorporating the IDCP component of invasive prostate cancer in the Gleason score are discussed in detail.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
231-239Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2020 The Authors. Histopathology published by John Wiley & Sons Ltd.
Références
Kovi J, Jackson MA, Heshmat MY. Ductal spread in prostatic carcinoma. Cancer 1985; 56; 1566-1573.
McNeal JE, Yemoto CE. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am. J. Surg. Pathol. 1996; 20; 802-814.
Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod. Pathol. 2006; 19; 1528-1535.
Epstein JI, Oxley J, Ro JY, Van der Kwast T, Zhou M. Tumours of the prostate: intraductal carcinoma. In Moch H, Humphrey PA, Ulbright TM, Reuter V eds. World Health Organization classification of tumours of the urinary system and male genital organs. LyonIARC Press, 2016; 64-165.
Epstein JI, Egevad L, Amin MB et al. The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am. J. Surg. Pathol. 2016; 40; 244-252.
van Leenders GJLH, van der Kwast TH, Grignon DJ et al. The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma. Am. J. Surg. Pathol. 2020; 44; e87-e99.
Epstein JI, Amin MB, Fine SW et al. The 2019 Genitourinary Pathology Society (GUPS) White Paper on contemporary grading of prostate cancer. Arch. Pathol. Lab. Med. [published online ahead of print, 2020 Jun 26] 2020. https://doi.org/10.5858/arpa.2020-0015-RA.
Khani F, Epstein JI. Prostate biopsy specimens with Gleason 3+3=6 and intraductal carcinoma: radical prostatectomy findings and clinical outcomes. Am. J. Surg. Pathol. 2015; 39; 1383-1389.
Varma M, Delahunt B, Egevad L, Samaratunga H, Kristiansen G. Intraductal carcinoma of the prostate: a critical re-appraisal. Virchows Arch. 2019; 474; 525-534.
Danneman D, Drevin L, Delahunt B et al. Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens. Nationwide trends 2000-2012. BJU Int. 2017; 119; 50-56.
Shah RB, Nguyen JK, Przybycin CG et al. Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes. Histopathology 2019; 75; 346-353.
Hickman RA, Yu H, Li J et al. Atypical intraductal cribriform proliferations of the prostate exhibit similar molecular and clinicopathologic characteristics as intraductal carcinoma of the prostate. Am. J. Surg. Pathol. 2017; 41; 550-556.
Iczkowski KA, Egevad L, Ma J et al. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists. Ann. Diagn. Pathol. 2014; 18; 333-342.
Fine SW, Al-Ahmadie HA, Chen YB, Gopalan A, Tickoo SK, Reuter VE. Comedonecrosis revisited: strong association with intraductal carcinoma of the prostate. Am. J. Surg. Pathol. 2018; 42; 1036-1041.
Madan R, Deebajah M, Alanee S et al. Prostate cancer with comedonecrosis is frequently, but not exclusively, intraductal carcinoma: a need for reappraisal of grading criteria. Histopathology 2019; 74; 1081-1087.
Gandhi JS, Smith SC, Paner GP et al. Reporting practices and resource utilization in the era of intraductal carcinoma of the prostate: a survey of genitourinary subspecialists. Am. J. Surg. Pathol. 2020; 44; 673-680.
Epstein JI, Allsbrook WC, Amin MB, Egevad L, ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostate carcinoma. Am. J. Surg. Pathol. 2005; 29; 1228-1242.
Miyai K, Divatia MK, Shen SS, Miles BJ, Ayala AG, Ro JY. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between ‘precursor-like’ and ‘regular type’ lesions. Int. J. Clin. Exp. Pathol. 2014; 7; 2518-2526.
Robinson BD, Epstein JI. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings. J. Urol. 2010; 184; 1328-1333.
Rijstenberg L, Hansum T, Hollemans E et al. Intraductal carcinoma has minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens. Histopathology [published online ahead of print, 2020 Jun 15]. 2020. https://doi.org/10.1111/his.14179.